Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-066818

Aclaris Therapeutics, Inc. · ACRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kamil Ali-Jackson
Officer — Chief Legal Officer
Period of report
Dec 15, 2017
Accepted (ET)
Dec 21, 2017 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 15, 2017M1,733—A78,438D
Common StockDec 15, 2017F527$24.23D77,911D
Common StockF1Dec 18, 2017M1,075—A78,986D
Common StockDec 18, 2017F327$24.12D78,659D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F3—Dec 15, 2017M1,733D——Common Stock1,73312,133D
Restricted Stock UnitsF1,F4—Dec 18, 2017M1,075D——Common Stock1,0752,150D

Explanation of responses